Infographic 30 Jan 2014

Research-based pharmaceutical industry’s 360-degree efforts to fight neglected tropical diseases (NTDs)

Read more
Report 29 Jan 2014

Assessing the value of biopharmaceutical innovation in key therapy areas in middle-income countries

Read more
Press release 29 Jan 2014

New study captures the value of new medicines in middle-income countries

Geneva, 29 January 2014 −An independent study conducted by Charles River Associates (CRA) demonstrates that there is clear evidence that innovative medicines have delivered significant value by reducing healthcare costs and benefitting both patients and wider society. However, there remains enormous untapped potential of adopting innovative medicines more widely in middle-income countries (MICs). This can...

Read more
Report 17 Jan 2014

The complex journey of a vaccine

Read more
Press release 13 Jan 2014

Putting patients first: Five global healthcare organizations sign Consensus Framework for Ethical Collaboration

Trust and respect are essential for advancing healthcare Based on shared overarching principles, the Consensus Framework puts patients first, supports ethical research and innovation, ensures independence and ethical conduct, and promotes transparency and accountability Highlights best practice for different groups collaborating to advance patient healthcare Five global healthcare organizations have established a Consensus Framework for...

Read more
Infographic 8 Jan 2014

The complex journey of a vaccine

Read more
Video 11 Dec 2013

IFPMA season’s greetings card 2013

Season’s greetings and best wishes for a prosperous 2014

Read more
Expert insight 26 Nov 2013

Fighting Fake Medicines is Everybody’s Business

In my capacity as IFPMA Director General, I have an interesting vantage point of how the various global health groups in Geneva and beyond – international organizations, NGOs, national governmental missions and industry – collectively tackle a range of global health issues. Collective action has led to important progress on HIV/AIDS, malaria, tuberculosis, neglected tropical...

Read more
Press release 22 Nov 2013

Ten global health organizations united in a worldwide campaign to protect patients from fake medicines

Fake medicines put patients and the general public at risk. Patients believe they are receiving genuine treatment, but instead they are getting potentially dangerous products that could increase resistance to real treatments, and cause further illness, disability or even death. Fight the Fakes campaign (www.fightthefakes.org) will raise awareness about the dangers of fake medicines by...

Read more
Infographic 18 Nov 2013

IFPMA’s 10 principles on counterfeit medicines

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) published its “Ten Principles on Counterfeit Medicines”  to draw public attention to the issue.

Read more
Expert insight 18 Nov 2013

Data over Dogma, What Can the HIV/AIDS Experience Teach us for Addressing the NCDs

The recent United Nations Summit on MDGs fueled the final push to achieve health-related Millennium Development Goals and focused attention on new Sustainable Development Goals (SDGs). It also caused me to revisit a 2011 report on improving access to drugs non-communicable diseases (NCDs) in developing countries and a report that I contributed to a John...

Read more
Video 14 Nov 2013

Watch out for false friends with Japanese subtitle / ニセ薬に気をつけろ! 日本語字幕

Every day, fake medicines find their way into online and physical pharmacies, hospitals, and street markets. This plague knows no borders. In the best case scenario, fake medicines leave patients with no side-effects but also without a cure. In many other cases, however, they can kill people. We have to get smarter than the criminals...

Read more